1. Home
  2. ALNT vs ABUS Comparison

ALNT vs ABUS Comparison

Compare ALNT & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALNT
  • ABUS
  • Stock Information
  • Founded
  • ALNT 1962
  • ABUS 2005
  • Country
  • ALNT United States
  • ABUS United States
  • Employees
  • ALNT N/A
  • ABUS N/A
  • Industry
  • ALNT Electrical Products
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALNT Industrials
  • ABUS Health Care
  • Exchange
  • ALNT Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • ALNT 777.2M
  • ABUS 711.2M
  • IPO Year
  • ALNT N/A
  • ABUS N/A
  • Fundamental
  • Price
  • ALNT $56.69
  • ABUS $4.61
  • Analyst Decision
  • ALNT Buy
  • ABUS Strong Buy
  • Analyst Count
  • ALNT 2
  • ABUS 2
  • Target Price
  • ALNT $47.50
  • ABUS $5.00
  • AVG Volume (30 Days)
  • ALNT 240.1K
  • ABUS 868.6K
  • Earning Date
  • ALNT 11-05-2025
  • ABUS 11-06-2025
  • Dividend Yield
  • ALNT 0.21%
  • ABUS N/A
  • EPS Growth
  • ALNT N/A
  • ABUS N/A
  • EPS
  • ALNT 0.85
  • ABUS N/A
  • Revenue
  • ALNT $519,604,000.00
  • ABUS $15,416,000.00
  • Revenue This Year
  • ALNT $3.38
  • ABUS $138.02
  • Revenue Next Year
  • ALNT $3.97
  • ABUS N/A
  • P/E Ratio
  • ALNT $66.63
  • ABUS N/A
  • Revenue Growth
  • ALNT N/A
  • ABUS 53.23
  • 52 Week Low
  • ALNT $17.16
  • ABUS $2.71
  • 52 Week High
  • ALNT $58.13
  • ABUS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • ALNT 67.44
  • ABUS 59.14
  • Support Level
  • ALNT $54.01
  • ABUS $4.26
  • Resistance Level
  • ALNT $56.99
  • ABUS $4.61
  • Average True Range (ATR)
  • ALNT 2.68
  • ABUS 0.21
  • MACD
  • ALNT 0.60
  • ABUS 0.01
  • Stochastic Oscillator
  • ALNT 87.90
  • ABUS 77.27

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: